BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27625046)

  • 21. Phagocytic function of human blood polymorphonuclear leukocytes in the presence of carrageenan, a potential vaginal microbicide.
    Malawista SE; de Boisfleury Chevance A
    Inflammation; 2007 Oct; 30(5):131-5. PubMed ID: 17562156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptability of Carraguard vaginal gel use among Thai couples.
    Whitehead SJ; Kilmarx PH; Blanchard K; Manopaiboon C; Chaikummao S; Friedland B; Achalapong J; Wankrairoj M; Mock P; Thanprasertsuk S; Tappero JW
    AIDS; 2006 Nov; 20(17):2141-8. PubMed ID: 17086053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Efficacy of a Coriolus versicolor-Based Vaginal Gel in Women with Cervical Uterine High-Risk HPV Infection: A Retrospective Observational Study.
    Criscuolo AA; Sesti F; Piccione E; Mancino P; Belloni E; Gullo C; Ciotti M
    Adv Ther; 2021 Feb; 38(2):1202-1211. PubMed ID: 33367986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of a carrageenan gel on viral load of genital human papillomavirus infections in sexually active women: Findings from the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) trial.
    Laurie C; El-Zein M; Tota JE; Tellier PP; Coutlée F; Burchell AN; Franco EL
    J Med Virol; 2024 Apr; 96(4):e29604. PubMed ID: 38606779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of a Coriolus versicolor-Based Vaginal Gel in Women With Human Papillomavirus-Dependent Cervical Lesions: The PALOMA Study.
    Serrano L; López AC; González SP; Palacios S; Dexeus D; Centeno-Mediavilla C; Coronado P; de la Fuente J; López JA; Vanrell C; Cortés J
    J Low Genit Tract Dis; 2021 Apr; 25(2):130-136. PubMed ID: 33746195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
    Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
    Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clearance of cervical human papillomavirus infection by topical application of curcumin and curcumin containing polyherbal cream: a phase II randomized controlled study.
    Basu P; Dutta S; Begum R; Mittal S; Dutta PD; Bharti AC; Panda CK; Biswas J; Dey B; Talwar GP; Das BC
    Asian Pac J Cancer Prev; 2013; 14(10):5753-9. PubMed ID: 24289574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety, persistence, and acceptability of an antiretroviral microbicide candidate UC781.
    Bunge K; Macio I; Meyn L; Noguchi L; Parniak MA; Schwartz JL; Moncla B; Hillier S
    J Acquir Immune Defic Syndr; 2012 Aug; 60(4):337-43. PubMed ID: 22495787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model.
    Roberts JN; Kines RC; Katki HA; Lowy DR; Schiller JT
    J Natl Cancer Inst; 2011 May; 103(9):737-43. PubMed ID: 21483020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan.
    Roberts JN; Buck CB; Thompson CD; Kines R; Bernardo M; Choyke PL; Lowy DR; Schiller JT
    Nat Med; 2007 Jul; 13(7):857-61. PubMed ID: 17603495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial.
    Politch JA; Cu-Uvin S; Moench TR; Tashima KT; Marathe JG; Guthrie KM; Cabral H; Nyhuis T; Brennan M; Zeitlin L; Spiegel HML; Mayer KH; Whaley KJ; Anderson DJ
    PLoS Med; 2021 Feb; 18(2):e1003495. PubMed ID: 33534791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers.
    Marais D; Carrara H; Kay P; Ramjee G; Allan B; Williamson AL
    Virus Res; 2006 Nov; 121(2):220-2. PubMed ID: 16860426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus.
    Holmes MM; Weaver SH; Vermillion ST
    Infect Dis Obstet Gynecol; 1999; 7(4):186-9. PubMed ID: 10449266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during, and after both simulated and real intercourse.
    Pretorius ES; Timbers K; Malamud D; Barnhart K
    Contraception; 2002 Dec; 66(6):443-51. PubMed ID: 12499038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.
    Fernández-Romero JA; Abraham CJ; Rodriguez A; Kizima L; Jean-Pierre N; Menon R; Begay O; Seidor S; Ford BE; Gil PI; Peters J; Katz D; Robbiani M; Zydowsky TM
    Antimicrob Agents Chemother; 2012 Jan; 56(1):358-68. PubMed ID: 22064530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.
    Skoler-Karpoff S; Ramjee G; Ahmed K; Altini L; Plagianos MG; Friedland B; Govender S; De Kock A; Cassim N; Palanee T; Dozier G; Maguire R; Lahteenmaki P
    Lancet; 2008 Dec; 372(9654):1977-87. PubMed ID: 19059048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples.
    Martinelli M; Latsuzbaia A; Bonde J; Pedersen H; Iacobone AD; Bottari F; Piana AF; Pietri R; Cocuzza CE; Arbyn M;
    Microbiol Spectr; 2024 Mar; 12(3):e0287223. PubMed ID: 38323823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.
    Kwak K; Jiang R; Wang JW; Jagu S; Kirnbauer R; Roden RB
    PLoS One; 2014; 9(5):e97232. PubMed ID: 24816794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive.
    Keller MJ; Carpenter CA; Lo Y; Einstein MH; Liu C; Fredricks DN; Herold BC
    PLoS One; 2012; 7(10):e46901. PubMed ID: 23056520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of a Carrageenan Gel in Increasing Clearance of Anal Human Papillomavirus Infections in Men: Interim Analysis of a Double-Blind, Randomized Controlled Trial.
    Laurie C; El-Zein M; Tota J; Khosrow-Khavar F; Tellier PP; Coutlée F; de Pokomandy A; Franco EL;
    J Infect Dis; 2023 Feb; 227(3):402-406. PubMed ID: 35090175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.